These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
684 related articles for article (PubMed ID: 3756897)
1. In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride. Berners-Price SJ; Mirabelli CK; Johnson RK; Mattern MR; McCabe FL; Faucette LF; Sung CM; Mong SM; Sadler PJ; Crooke ST Cancer Res; 1986 Nov; 46(11):5486-93. PubMed ID: 3756897 [TBL] [Abstract][Full Text] [Related]
2. In vivo development and in vitro characterization of a subclone of murine P388 leukemia resistant to bis(diphenylphosphine)ethane. Hoke GD; McCabe FL; Faucette LF; Bartus JO; Sung CM; Jensen BD; Heys JR; Rush GF; Alberts DW; Johnson RK Mol Pharmacol; 1991 Jan; 39(1):90-7. PubMed ID: 1898982 [TBL] [Abstract][Full Text] [Related]
3. Modulation of the antitumor and biochemical properties of bis(diphenylphosphine)ethane with metals. Snyder RM; Mirabelli CK; Johnson RK; Sung CM; Faucette LF; McCabe FL; Zimmerman JP; Whitman M; Hempel JC; Crooke ST Cancer Res; 1986 Oct; 46(10):5054-60. PubMed ID: 3756863 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models. Mirabelli CK; Johnson RK; Sung CM; Faucette L; Muirhead K; Crooke ST Cancer Res; 1985 Jan; 45(1):32-9. PubMed ID: 3917372 [TBL] [Abstract][Full Text] [Related]
5. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice. Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799 [TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152). Fujimoto K; Oka T; Morimoto M Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218 [TBL] [Abstract][Full Text] [Related]
7. Mechanism of toxicity of an experimental bidentate phosphine gold complexed antineoplastic agent in isolated rat hepatocytes. Smith PF; Hoke GD; Alberts DW; Bugelski PJ; Lupo S; Mirabelli CK; Rush GF J Pharmacol Exp Ther; 1989 Jun; 249(3):944-50. PubMed ID: 2732955 [TBL] [Abstract][Full Text] [Related]
8. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide. Burres NS; Clement JJ Cancer Res; 1989 Jun; 49(11):2935-40. PubMed ID: 2720652 [TBL] [Abstract][Full Text] [Related]
9. The synthesis, chemical and biological properties of dichlorido(azpy)gold(III) chloride (azpy=2-(phenylazo)pyridine) and the gold-induced conversion of the azpy ligand to the chloride of the novel tricyclic pyrido[2,1-c][1,2,4]benzotriazin-11-ium cation. Garza-Ortiz A; den Dulk H; Brouwer J; Kooijman H; Spek AL; Reedijk J J Inorg Biochem; 2007 Nov; 101(11-12):1922-30. PubMed ID: 17637477 [TBL] [Abstract][Full Text] [Related]
10. Cellular pharmacology of mu-[1,2-bis(diphenylphosphino)ethane]bis[(1-thio-beta-D-gluco pyranosato-S)gold(I)]: a novel antitumor agent. Mirabelli CK; Jensen BD; Mattern MR; Sung CM; Mong SM; Hill DT; Dean SW; Schein PS; Johnson RK; Crooke ST Anticancer Drug Des; 1986 Nov; 1(3):223-34. PubMed ID: 3450295 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, physical properties, and antitumor activity of tetraplatin and related tetrachloroplatinum(IV) stereoisomers of 1,2-diaminocyclohexane. Anderson WK; Quagliato DA; Haugwitz RD; Narayanan VL; Wolpert-DeFilippes MK Cancer Treat Rep; 1986 Aug; 70(8):997-1002. PubMed ID: 3731155 [TBL] [Abstract][Full Text] [Related]
12. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro. Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127 [TBL] [Abstract][Full Text] [Related]
13. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines. Tsuruo T; Yusa K; Sudo Y; Takamori R; Sugimoto Y Cancer Res; 1989 Oct; 49(20):5537-42. PubMed ID: 2790778 [TBL] [Abstract][Full Text] [Related]
14. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo. Elliott WL; Roberts BJ; Howard CT; Leopold WR Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790 [TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of the mixed phosphine gold species chlorotriphenylphosphine-1,3-bis(diphenylphosphino)propanegold(I). Caruso F; Rossi M; Tanski J; Pettinari C; Marchetti F J Med Chem; 2003 Apr; 46(9):1737-42. PubMed ID: 12699391 [TBL] [Abstract][Full Text] [Related]
16. Chemical behavior and in vitro activity of mixed phosphine gold(I) compounds on melanoma cell lines. Caruso F; Pettinari C; Paduano F; Villa R; Marchetti F; Monti E; Rossi M J Med Chem; 2008 Mar; 51(6):1584-91. PubMed ID: 18307291 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial and anticancer activity of tetrahedral, chelated, diphosphine silver(I) complexes: comparison with copper and gold. Berners-Price SJ; Johnson RK; Giovenella AJ; Faucette LF; Mirabelli CK; Sadler PJ J Inorg Biochem; 1988 Aug; 33(4):285-95. PubMed ID: 3139831 [TBL] [Abstract][Full Text] [Related]
18. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice. Cantrell JE; Green D; Schein PS Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of cytotoxicity of copper(I) complexes of 1,2-bis(diphenylphosphino)ethane. Sanghamitra NJ; Phatak P; Das S; Samuelson AG; Somasundaram K J Med Chem; 2005 Feb; 48(4):977-85. PubMed ID: 15715467 [TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of novel ailanthone derivatives in vitro and in vivo. Kato T; Suzumura Y; Fukushima M; Honda T; Nakanishi T; Noguchi T Anticancer Res; 1988; 8(4):573-9. PubMed ID: 3178149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]